HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[EHF-therapy of herpetic keratouveitis].

Abstract
A device BIK for active suppression of infection has been used against Herpes virus infection type 1 and 2 in 72 patients with keratouveitis. The immunological and genotypic monitoring show that patients with herpetic keratouveitis after BIK treatment have lower titers of antiherpetic antibodies, normal cellular and humoral immunity, weaker viremia and reduced quantity of viral material in corneal tissue. This positive effect persisted for 8-12 months. Thus, BIK device provides a definite, prolonged and stable therapeutic effect in patients with herpetic keratouveitis.
AuthorsM Iu Gerasimenko, A A Riabtseva, N L Goncharenko, S V Suchkov, E V Kuvshinov, E V Filatova
JournalVoprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury (Vopr Kurortol Fizioter Lech Fiz Kult) 2002 Jul-Aug Issue 4 Pg. 34-7 ISSN: 0042-8787 [Print] Russia (Federation)
Vernacular TitleKVCh-terapiia gerpeticheskikh keratouveitov.
PMID12380532 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Electromagnetic Phenomena (instrumentation, methods)
  • Herpesvirus 1, Human (radiation effects)
  • Herpesvirus 2, Human (radiation effects)
  • Humans
  • Keratitis, Herpetic (therapy, virology)
  • Middle Aged
  • Uveitis (therapy, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: